Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

204.07 -12.51 (-5.78%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

25 26 Next >

3 Fierce Stocks That Are Screaming Buys in December ↗

December 07, 2022

Here are three winners in the making.

Via The Motley Fool

Axsome Therapeutics Presents New Data from the EVOLVE Open-Label Trial Demonstrating Effects of AUVELITY® on Cognitive and Physical Functioning in Patients with Major Depressive Disorder at the American College of Neuropsychopharmacology (ACNP) 2022

December 07, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

Got $2,000? 3 Growth Stocks to Buy That Could Double Your Money ↗

December 07, 2022

There's no guarantee of 100% returns for these stocks, but their chances look pretty good.

Via The Motley Fool

12 Top Stocks to Buy in December ↗

December 03, 2022

Add this dandy dozen to your stocking this month.

Via The Motley Fool

Axsome Therapeutics Stock: Bear vs. Bull ↗

December 02, 2022

2023 will almost certainly see Axsome's top line explode higher.

Via The Motley Fool

Axsome Therapeutics's Return On Capital Employed Insights ↗

November 30, 2022

Via Benzinga

Analyst Ratings for Axsome Therapeutics ↗

November 29, 2022

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $13,000 Today ↗

November 28, 2022

Via Benzinga

Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review ↗

December 02, 2022

The S&P 500 is fighting for its 200-day, a critical level for the uptrend.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

November 30, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Struggling Axsome Stock Could Bounce Back on Drug Trial Success

November 30, 2022

Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that.

Via MarketBeat

FedEx To Rally Over 25%? Here Are 10 Other Price Target Changes For Tuesday ↗

November 29, 2022

Keybanc lowered Salesforce, Inc. (NYSE: CRM) price target from $210 to $200. . Keybanc analyst Michael Turits maintained an Overweight rating on the stock. Salesforce shares gained 0.5% to $154.45 in...

Via Benzinga

Tesla, Apple, Anavex, Axsome, Pinduoduo: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

November 28, 2022

Major Wall Street indices closed over 1% lower on Monday after protests in China against COVID-zero policies led to supply chain concerns.

Via Benzinga

Dow Tumbles 450 Points; S&P 500 Falls 1.5% ↗

November 28, 2022

U.S. stocks traded lower toward the end of trading amid protests over COVID-19 restrictions in China. The Dow Jones dropped more than 450 points on Monday.

Via Benzinga

10 Things to Know as Tesla Revamps Model 3 With Project ‘Highland’ ↗

November 28, 2022

Recent reports claim that Tesla (TSLA) is planning to revamp the Model 3 under the secret "Highland" project and we have the details!

Via InvestorPlace

Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

November 28, 2022

Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.

Via Benzinga

Swvl Layoffs 2022: What to Know About the Latest SWVL Job Cuts ↗

November 28, 2022

Swvl (SWVL) layoffs are here again as the micro-mobility company seeks to reduce costs by cutting more than 50% of its workforce.

Via InvestorPlace

10 Health Care Stocks Whale Activity In Today's Session ↗

November 28, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Why Is Axsome Therapeutics (AXSM) Stock Up 32% Today? ↗

November 28, 2022

Axsome Therapeutics (AXSM) stock is soaring higher on Monday after releasing positive results from a Phase 3 clinical trial.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 28, 2022

Via Benzinga

Stocks Stumbling After Thanksgiving Week ↗

November 28, 2022

The Dow Jones Industrial Average is extending its premarket losses, down 265 points at midday, as protests in China over the country's zero-Covid policy weigh on investor sentiment globally.

Via Talk Markets

Dow Tumbles Over 200 Points; Axsome Therapeutics Shares Spike Higher ↗

November 28, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Monday.

Via Benzinga

US Stocks Start Week On Lower Note, Dow Drops Over 100 Points ↗

November 28, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Monday.

Via Benzinga

Axsome Therapeutics Unusual Options Activity ↗

November 28, 2022

Someone with a lot of money to spend has taken a bullish stance on Axsome Therapeutics (NASDAQ:AXSM). And retail traders should know. We noticed this today when the big position showed up on publicly...

Via Benzinga

Analyst Says Coinbase 'A Waste Of Time', Taylor Swift's Concert Fiasco Under DOJ Probe, Shopify Clocks Record Black Friday Sales: Top Stories Monday, Nov. 28 ↗

November 28, 2022

CNBC

Via Benzinga

Biogen Dives On Reports Of Alzheimer's Death While Axsome Soars On Its Study Success ↗

November 28, 2022

Biogen and Axsome stocks diverged Monday on news out of their Alzheimer's studies.

Via Investor's Business Daily

Why Axsome Therapeutics Stock Is Soaring Today ↗

November 28, 2022

Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday morning after the company announced AXS-05 achieved its primary endpoint in the ACCORD Phase 3 trial in Alzheimer's disease...

Via Benzinga

Axsome Therapeutics Investigational Drug Lowers Risk Of Agitation Relapse In Alzheimer's Patients ↗

November 28, 2022

Axsome Therapeutics Inc's (NASDAQ: AXSM) AXS-05 substantially and statistically significantly delayed the time to relapse and prevented relapse of agitation in patients with Alzheimer's disease,...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 28, 2022

Via Benzinga

Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in the ACCORD Phase 3 Trial in Alzheimer’s Disease Agitation

November 28, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2

...

13 14 15 16 17 18 19 20 21

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.